<DOC>
	<DOCNO>NCT00440011</DOCNO>
	<brief_summary>Patients glaucoma ocular hypertension currently treat latanoprost 0.005 % , need additional IOP lowering , randomize receive either bimatoprost 0.03 % travoprost 0.004 % place latanoprost 0.005 %</brief_summary>
	<brief_title>Bimatoprost 0.03 % Versus Travoprost 0.004 % Patients Currently Latanoprost 0.005 %</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Glaucoma ocular hypertension eye Currently treat latanoprost 0.005 % daily need additional IOPlowering Bestcorrected visual acuity 20/100 good eye Visual field within 6 month study entry Secondary glaucoma Active intraocular inflammation macular edema Intraocular surgery laser surgery within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>